Nuveen Asset Management, LLC Emergent Bio Solutions Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.35 - $13.21 $595,305 - $1.07 Million	-80,994 Reduced 59.04%	56,201 $413,000
Q1 2023 May 15, 2023	SELL	$7.79 - $16.29 $89,631 - $187,432	-11,506 Reduced 7.74%	137,195 $1.42 Million
Q4 2022 Feb 14, 2023	SELL	$11.0 - $21.45 $245,025 - $477,798	-22,275 Reduced 13.03%	148,701 $1.76 Million
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $41,465 - $73,891	-2,064 Reduced 1.19%	170,976 $3.59 Million
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $117,001 - $186,169	-4,267 Reduced 2.41%	173,040 $5.37 Million
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $689,362 - $986,801	-18,897 Reduced 9.63%	177,307 $7.36 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $504,397 - $838,022	-15,234 Reduced 7.2%	196,204 $8.53 Million
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $5.73 Million - $7.56 Million	-114,521 Reduced 35.13%	211,438 $10.6 Million
Q2 2021 Aug 16, 2021	SELL	$56.61 - $80.46 $4.59 Million - $6.52 Million	-81,025 Reduced 19.91%	325,959 $20.5 Million
Q1 2021 May 17, 2021	BUY	$86.23 - $125.19 $3.59 Million - $5.21 Million	41,594 Added 11.38%	406,984 $37.8 Million
Q4 2020 May 17, 2021	BUY	$79.17 - $111.47 $2.96 Million - $4.17 Million	37,375 Added 11.39%	365,390 $32.7 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $1.32 Million - $1.86 Million	16,712 Added 5.37%	328,015 $29.4 Million
Q3 2020 Nov 16, 2020	BUY	$81.91 - $134.94 $2.28 Million - $3.75 Million	27,821 Added 9.81%	311,303 $32.2 Million
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $906,550 - $1.49 Million	16,686 Added 6.25%	283,482 $22.4 Million
Q1 2020 May 14, 2020	BUY	$49.34 - $68.76 $1.55 Million - $2.16 Million	31,481 Added 13.38%	266,796 $15.4 Million
Q4 2019 Feb 14, 2020	BUY	$51.21 - $59.06 $2.45 Million - $2.83 Million	47,912 Added 25.57%	235,315 $12.7 Million
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $545,785 - $768,939	-13,443 Reduced 6.69%	187,403 $9.8 Million
Q2 2019 Aug 15, 2019	BUY	$39.92 - $53.86 $6.79 Million - $9.16 Million	170,018 Added 551.51%	200,846 $9.7 Million
Q1 2019 May 14, 2019	BUY	$48.23 - $66.16 $315,665 - $433,017	6,545 Added 26.95%	30,828 $1.56 Million
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $640,635 - $843,431	-11,516 Reduced 32.17%	24,283 $1.44 Million
Q3 2018 Nov 13, 2018	SELL	$52.05 - $66.51 $1.03 Million - $1.32 Million	-19,802 Reduced 35.61%	35,799 $2.36 Million
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $151,031 - $173,875	3,125 Added 5.96%	55,601 $2.81 Million
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $239,398 - $292,998	5,387 Added 11.44%	52,476 $2.76 Million
Q4 2017 Feb 14, 2018	SELL	$37.77 - $47.75 $315,946 - $399,428	-8,365 Reduced 15.08%	47,089 $0
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $1.89 Million - $2.24 Million	55,454	55,454 $2.24 Million

Others Institutions Holding EBS

# of Institutions

154

Shares Held

30.2M

Call Options Held

137K

Put Options Held

706K

Black Rock Inc. New York, NY

3.84M
Shares

$32.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.67M
Shares

$30.6 Million
0.0% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

3.17M
Shares

$26.4 Million
0.0% of portfolio
Morgan Stanley New York, NY

1.24M
Shares

$10.4 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

946K
Shares

$7.9 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $416M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account